Biopharmaceutical company Alumis has promoted Sara Klein to the position of Chief Legal Officer. The announcement, made on Tuesday, outlines Klein’s expanded responsibilities in directing corporate legal and compliance matters, including corporate governance and intellectual property, while also advising on strategic decisions and transactions. Alumis, a clinical-stage company, continues to bolster its leadership team with this new appointment.
Klein joined Alumis in 2022 as General Counsel and has been instrumental in navigating the legal landscape for the company. Her expertise is expected to further fortify the company’s strategic legal framework as it advances its portfolio of pharmaceutical innovations. In addition to Klein’s promotion, Jack Danilkowicz has been appointed to a newly created role of Chief Commercial Officer within the company.
The announcement of Klein’s promotion comes amidst a series of leadership enhancements at Alumis, as detailed in the company’s official release.
This move is part of Alumis’ broader strategy to strengthen its leadership and enhance its operational framework as it positions itself in the competitive biotech marketplace. For further details on the announcement, you can view the full article at Bloomberg Law.